ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,00%
Bitcoin
66.944,72
-0,20%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Biodesix Inc (BDSX)

  7. Biodesix Inc (BDSX) News

BDSX

Biodesix (BDSX)

Biodesix Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BDSX
DatumZeitQuelleÜberschriftSymbolFirma
10/05/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
10/05/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
10/05/202423h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
10/05/202423h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
10/05/202423h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
09/05/202422h07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
09/05/202422h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
09/05/202422h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
09/05/202422h04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
08/05/202422h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDSXBiodesix Inc
08/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDSXBiodesix Inc
08/05/202422h01Business WireBiodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule ManagementNASDAQ:BDSXBiodesix Inc
07/05/202412h00Business WireBiodesix to Participate in the 2024 RBCCM Global Healthcare ConferenceNASDAQ:BDSXBiodesix Inc
24/04/202412h00Business WireBiodesix to Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:BDSXBiodesix Inc
09/04/202423h00Business WireBiodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual MeetingNASDAQ:BDSXBiodesix Inc
05/04/202413h17Business WireBiodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private PlacementNASDAQ:BDSXBiodesix Inc
25/03/202411h00Business WireBiodesix Announces New Master Collaborative Research Agreement with Leading US Cancer CenterNASDAQ:BDSXBiodesix Inc
01/03/202412h11Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BDSXBiodesix Inc
01/03/202412h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDSXBiodesix Inc
01/03/202412h00Business WireBiodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business HighlightsNASDAQ:BDSXBiodesix Inc
01/03/202400h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
01/03/202400h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
01/03/202400h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
01/03/202400h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
01/03/202400h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
26/02/202412h00Business WireBiodesix to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:BDSXBiodesix Inc
16/02/202412h00Business WireBiodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024NASDAQ:BDSXBiodesix Inc
13/02/202403h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
13/02/202403h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
13/02/202403h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
 Showing the most relevant articles for your search:NASDAQ:BDSX

Kürzlich von Ihnen besucht

BIT
UC4AYH
Unicredit Bank
USOTC
RSJBS
RSE Archive (GM)
BIT
F12611
Vontobel Financial Produ...
EU
9158S
9158S
HITB
MASKUSD
Mask Network
NASDAQ
SOFO
Sonic Foundry
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten